(2015). Macrophages are critical effectors of antibody therapies for cancer. mAbs: Vol. 7, No. 2, pp. 303-310.
Via Krishan Maggon
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Your new post is loading...
Your new post is loading...
|
pages 303-310
Publishing models and article dates explainedReceived: 4 Jan 2015Accepted: 15 Jan 2015Accepted author version posted online: 10 Feb 2015Article Views: 321pages 303-310
Publishing models and article dates explainedReceived: 4 Jan 2015Accepted: 15 Jan 2015Accepted author version posted online: 10 Feb 2015Article Views: 321